Literature DB >> 9171906

Serotonin transporter binding sites and mRNA levels in depressed persons committing suicide.

K Y Little1, D P McLauglin, J Ranc, J Gilmore, J F Lopez, S J Watson, F I Carroll, J D Butts.   

Abstract

The serotonin transporter (5-HTT) has been found altered in postmortem brain samples from persons committing suicide, but the results of radioligand binding studies have been inconsistent. In the present series of experiments, autoradiographic radioligand binding and in situ hybridization techniques were utilized to examine 5-HTT function in the brains of 8 depressed subjects who had committed suicide, and matched controls. It was hypothesized that depressed subjects would demonstrate decreased numbers of 5-HTT binding sites and mRNA; however, [125I]RTI-55 binding to the 5-HTT was not different in the midbrain, hippocampus, or frontal cortex of depressed subjects. Also, 5-HTT mRNA levels in dorsal and median raphe nuclei were not different between controls and depressed subjects. The current results, although limited in scope because of the small number of subjects included, offer no evidence that alterations in the 5-HTT occur in pertinent brain regions of depressed individuals.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9171906     DOI: 10.1016/s0006-3223(96)00301-0

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  15 in total

1.  The genetic basis of addictive disorders.

Authors:  Francesca Ducci; David Goldman
Journal:  Psychiatr Clin North Am       Date:  2012-06

2.  Serotonin transport kinetics correlated between human platelets and brain synaptosomes.

Authors:  Jeffrey L Rausch; Maria E Johnson; Junqing Li; Julian Hutcheson; Benjamin M Carr; Katina M Corley; Amanda B Gowans; Joseph Smith
Journal:  Psychopharmacology (Berl)       Date:  2005-02-22       Impact factor: 4.530

Review 3.  An overview of the neurobiology of suicidal behaviors as one meta-system.

Authors:  M Sokolowski; J Wasserman; D Wasserman
Journal:  Mol Psychiatry       Date:  2014-09-02       Impact factor: 15.992

4.  Serotonin transporter promoter gain-of-function genotypes are linked to obsessive-compulsive disorder.

Authors:  Xian-Zhang Hu; Robert H Lipsky; Guanshan Zhu; Longina A Akhtar; Julie Taubman; Benjamin D Greenberg; Ke Xu; Paul D Arnold; Margaret A Richter; James L Kennedy; Dennis L Murphy; David Goldman
Journal:  Am J Hum Genet       Date:  2006-03-28       Impact factor: 11.025

5.  Fluoxetine-induced alterations in human platelet serotonin transporter expression: serotonin transporter polymorphism effects.

Authors:  Karley Y Little; Lian Zhang; Edwin Cook
Journal:  J Psychiatry Neurosci       Date:  2006-09       Impact factor: 6.186

Review 6.  Imaging genomics applied to anxiety, stress response, and resiliency.

Authors:  Ke Xu; Monique Ernst; David Goldman
Journal:  Neuroinformatics       Date:  2006

Review 7.  Imaging the serotonin transporter during major depressive disorder and antidepressant treatment.

Authors:  Jeffrey H Meyer
Journal:  J Psychiatry Neurosci       Date:  2007-03       Impact factor: 6.186

8.  Adverse early life experience and social stress during adulthood interact to increase serotonin transporter mRNA expression.

Authors:  Katherine L Gardner; Matthew W Hale; Stafford L Lightman; Paul M Plotsky; Christopher A Lowry
Journal:  Brain Res       Date:  2009-09-23       Impact factor: 3.252

9.  Transcriptional expression of serotonergic regulators in laser-captured microdissected dorsal raphe neurons of subjects with major depressive disorder: sex-specific differences.

Authors:  Dharmendra B Goswami; Warren L May; Craig A Stockmeier; Mark C Austin
Journal:  J Neurochem       Date:  2009-10-29       Impact factor: 5.372

10.  Serotonin receptor subtype and p11 mRNA expression in stress-relevant brain regions of suicide and control subjects.

Authors:  Hymie Anisman; Lisheng Du; Mikos Palkovits; Gabor Faludi; Gabor G Kovacs; Peter Szontagh-Kishazi; Zul Merali; Michael O Poulter
Journal:  J Psychiatry Neurosci       Date:  2008-03       Impact factor: 6.186

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.